Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria

Nature Genetics

Volumn 12, Issue 2, 1996, Pages 195-199

  Lindberg, Raija L P ^a   Porcher, Catherine ^b   Grandchamp, Bernard ^b   Ledermann, Birgit ^c   Bürki, Kurt ^c   Brandner, Sebastian ^d   Aguzzi, Adriano ^d   Meyer, Urs A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b INSERM   (France)

^c Preclinical Research   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; AMINOLEVULINIC ACID; HEME; PHENOBARBITAL; PORPHOBILINOGEN DEAMINASE;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENE TARGETING; HEME SYNTHESIS; MALE; MENTAL DISEASE; MOUSE; MUSCLE ATROPHY; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION;

AMINOLEVULINIC ACID; ANIMALS; ATROPHY; AXONS; BASE SEQUENCE; CHIMERA; DISEASE MODELS, ANIMAL; FEMALE; GENE TARGETING; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; KIDNEY; LIVER; MALE; MICE; MOLECULAR SEQUENCE DATA; MOTOR ACTIVITY; MUSCLE, SKELETAL; NERVOUS SYSTEM DISEASES; PHENOBARBITAL; PORPHYRIA, ACUTE INTERMITTENT; RNA, MESSENGER;

EID: 0030069657     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0296-195     Document Type: Article

References (26)

1. Kappas, A., Sassa, S., Galbraith, R.A. & Nordmann, Y. The porphyrias. In The Metabolic Basis of Inherited Disease (eds Scriver, C. et al.) 1306-1365 (New York, McGraw-Hill, 1989).
2. Elder, G.H. Molecular genetics of disorders of haem biosynthesis. J. Clin. Pathol. 46, 977-981 (1993).
3. Bonkovsky, H.L. Advances in understanding and treating 'the little imitator', acute porphyria. Gastroenterology 105, 590-594 (1993).
4. Tishler, P. V. et al. High prevalence of acute intermittent porphyria in a psychiatric patient population. Am. J. Psychiat. 142, 1430-1436 (1985).
5. Ledermann, B. & Bürki, K. Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp. Cell Res. 197, 254-258 (1991).
6. Grandchamp, B. et al. Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene. Eur. J. Biochem. 162, 105-110 (1987).
7. Beaumont, C., Porcher, C., Picat, C., Nordmann, Y. & Grandchamp, B. The mouse porphobilinogen deaminase gene. Structural organization, sequence and transcriptional analysis. J. Biol. Chem. 264, 14829-14834 (1989).
8. Johnson, P. & Friedmann, T. Limited bidirectional activity of two housekeeping gene promoters: human HPRT and PGK. Gene 88, 207-213 (1990).
9. Eales, L. & Dowdle, E.B. The acute porphyric attack I. The electrolyte disorder of the acute porphyric attack and the possible role of delta-aminolevulinic acid. S. Afr. J. Lab. Clin. Med. 17, 89-97 (1971).
10. Andersson, C. & Lithner, F. Hypertension and renal disease in patients with acute intermittent porphyria. J. Int. Med. 236, 169-175 (1994).
11. Cavanagh, J.B. & Mellick, R.S. On the nature of the peripheral nerve lesions associated with acute intermittent porphyria. J. Neurol. Neurosurg. Psychiat. 28, 320-327 (1965).
12. Hruska, R.E., Kennedy, S. & Silbergeld, E.K. Quantitative aspects of normal locomotion in rats. Life Sci. 25, 171-180 (1979).
13. Medinaceli, L., Freed, W.J. & Wyatt, R.J. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Expl. Neurol. 77, 634-643 (1982).
14. Albers, J.W., Robertson, W.C. & Daube, J.R. Electrodiagnostic findings in acute porphyric neuropathy. Muscle Nerve 1, 292-296 (1978).
15. Bonkowsky, H.L. & Schady, W. Neurologic Manifestations of Acute Porphyria in Seminar Liver Dis. 2, 108-124 (1982).
16. Müller, W.E. & Snyder, S.H. δ-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. Ann. Neurol. 2, 340-342 (1977).
17. Brennan, M.J.W. & Cantrill, R.C. δ-Aminolaevulinic acid is a potent agonist for GABA autoreceptor. Nature 280, 514-515 (1979).
18. Litman, D.A. & Correia, M. A. L-Tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria. Science 222, 1031-1033 (1983).
19. Nordmann, Y., de Verneuil, H., Deybach, J.-C., Delfau, M.-H. & Grandchamp, B. Molecular genetics of porphyrias. Am. Med. 22, 387-391 (1990).
20. Louie, G.V. et al. Structure of porphobilinogen deaminase reveals a flexible multidomain polymerase with a single catalytic site. Nature 359, 33-39 (1992).
21. Brownlie, P. D. et al. The three-dimensional structures of mutants of porphobilinogen deaminase: Toward an understanding of the structural basis of acute intermittent porphyria. Protein Sci. 3, 1644-1650 (1994).
22. Chen C.-H., Astrin, K.H., Lee, G., Anderson, K.E. & Desnick, R.J. Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. J. Clin. Invest. 94, 1927-1937 (1994).
23. Meyer, U.A., Strand, L.J., Doss, M., Rees, A.C. & Marver, H.S. Intermittent acute porphyria: demostration of a genetic defect in porphobilinogen metabolism. N. Engl. J. Med. 286, 1277-1282 (1972).
24. Poland, A. & Glover, E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin: a potent inducer of aminolevulinic acid synthetase. Science 179, 476-477 (1972).
25. Tomokuni, K., Ichiba, M., Hirai, Y. & Hasegawa, T. Optimized liquid-chromatographic method for fluorometric determination of urinary δ-aminolevulinic acid in workers exposed to lead. Clin. Chem. 33, 1665-1667 (1987).
26. Bielchowsky M. Die Silber-Imprägnation der Neurofibrillen. J. Psychol. Neurol. 3, 169-188 (1904).